Time for reappraisal of progesterone-receptor testing in breast cancer management [8]

Journal of Clinical Oncology

Volumn 23, Issue 12, 2005, Pages 2870-2871

  MacGrogan, Gaëtan ^a   De Mascarel, Isabelle ^a   Sierankowski, Ghyslaine ^a   Mauriac, Louis ^a   Debled, Marc ^a   Durand, Michel ^a   Tunon De Lara, Christine ^a   Avril, Antoine ^a   Picot, Véronique ^a   Mathoulin Pélissier, Simone ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOAL; DEXTRAN; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; ESTROGEN RECEPTOR;

BREAST CANCER; CANCER MODEL; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; DRUG RESEARCH; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; NOTE; PATHOLOGY; PATIENT CARE PLANNING; PREDICTION AND FORECASTING;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PATIENT CARE PLANNING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 21044458268     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.241     Document Type: Letter

References (3)

1. Banerjee M, George J, Song EY, et al: Tree-based model for breast cancer prognostication. J Clin Oncol 22:2567-2575, 2004
2. Olivotto IA, Truong PT, Speers CH, et al: Time to stop progesterone receptor testing in breast cancer management. J Clin Oncol 22:1769-1770, 2004
3. MacGrogan G, Soubeyran I, de Mascarel I, et al: Immunohistochemical detection of progesterone receptors in breast invasive ductal carcinomas: A correlative study of 942 cases. Appl Immunohistochem 4:219-227, 1996